IDBI Healthcare Fund: A Healthy Proposition For Your Investment Portfolio?
Feb 13, 2019

Author: Aditi Murkute

(Image source: unsplash.com)

IDBI Mutual fund launches an open-ended sectoral fund, IDBI Healthcare Fund (IDBIHF) that will invest mostly into stocks of companies of healthcare and its allied sector.

A sectoral fund is a sub-category of equity mutual fund that invests in companies of one particular sector of the market. Sector funds are a very-high-risk very-high-return investment proposition, as the fortune of the fund is closely linked to the undercurrents of a specific sector, although it could invest across the market capitalization spectrum.

Last year two new initiatives were announced under Ayushman Bharat by the government to improve health care system holistically. The overall healthcare industry is showing signs of improvement and Indian Pharma companies are faring well globally too. Plus, there is an increase in number of companies that are serving directly or indirectly to form a part of healthcare and its allied sectors.

IDBIHF wants to tap the growth opportunity due to the improvements in the healthcare and allied sectors.

IDBIHF will mainly aim to invest predominantly in companies that are part of healthcare and allied sector but may take a smaller exposure to equity and equity-related securities of other companies, debt and money market Securities, and Units issued by REITs & InvITs as well for risk mitigation and diversification purposes.

Table 1: NFO Details of IDBIHF

Type An open-ended equity scheme investing in Healthcare and Allied sectors Category Sectoral Fund
Investment Objective To achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in the Healthcare and Allied sectors.
However, there can be no assurance that the investment objective of the scheme will be realized.
Min. Investment Rs 5,000 and in multiples of Re. 1 thereafter. Face Value Rs 10 per unit
Plans  • Regular

• Direct
Options • Growth *
• Dividend
    ❍ Pay-out Dividend
    ❍ Reinvest Dividend
    ❍ Sweep-of Dividend
* default option
Entry Load Nil Exit Load (Repurchase/Switch-out/Transfer/SWP) - 1% for exit within 12 months from the date of allotment
Fund Manager Ms Uma Venkatraman Benchmark Index S&P BSE Healthcare - Total Return Index (TRI)
Issue Opens 8th February 2019 Issue Closes: 22nd February 2019
(Source: Scheme Information Document)


What is the Asset Allocation of IDBI Healthcare Fund?

Under normal circumstances, the scheme's asset allocation or asset distribution weight will be as under.

Table 2: IDBIHF's Asset Allocation

Instruments Indicative Allocation (% of Total Assets) Risk Profile
Minimum Maximum
Equity & Equity related instruments of companies engaged in the Healthcare and Allied Sectors 80 100 High
Equity and Equity related instruments of companies engaged in other than Healthcare and Allied Sectors 0 20 High
Debt and Money Market instruments including Mutual Fund Liquid Schemes 0 20 Low to Medium
Units issued by Real Estate Investment Trusts (REITs) & Infrastructure Investment Trusts (InvITs) 0 10 Medium to High
(Source: Scheme Information Document)


The scheme may invest up to 50% of Net Assets of Scheme into equity derivatives instruments. Investment in derivatives shall be for hedging, portfolio balancing and such other purposes as may be permitted from time to time.

The Scheme will not invest in Securitized Debt/ ADRs/GDRs, foreign securities.

The scheme may also enter into repurchase (repo) agreement and reverse repurchase agreement in government securities held by it as per the guidelines and regulations applicable to such transactions. The scheme will not invest in Repo in Corporate Debt Securities.

[Read: Why You Should Not Ignore Personalized Asset Allocation While Investing]

What is the Investment Strategy of the Scheme?

The Scheme will invest predominantly in the companies engaged in Healthcare and Allied Sectors. The Portfolio will primarily comprise of the stocks of the companies which are likely to benefit either directly or indirectly from the Healthcare and Allied sectors. Fund Manager may select the stocks of companies engaged in following-

  • Pharmaceutical,

  • Healthcare,

  • Hospitals & Diagnostics,

  • Insurance,

  • Wellness,

  • Nutrition,

  • Health IT services,

  • Research and/or Manufacturing Services,

  • Distribution,

  • Chemicals (Bulk, Specialty, Agrochemicals, Others),

  • Medical Equipment,

  • Hygiene,

  • And any other services that directly or indirectly forming part of the healthcare and allied sectors

To achieve the diversification, Fund Manager may also invest up to 20% of the net assets of the Scheme in equities and equity-related securities of companies engaged in other than Healthcare and Allied sectors. The Scheme will invest across the market capitalization predominantly in healthcare and allied sector space.

The Scheme also may invest in IPOs of companies which could be classified under Healthcare and Allied sector on listing.

Every stock which will eventually form part of the Portfolio will be analysed by in-house Equity Research Team and will be monitored on an ongoing basis for its merits and fundamentals like-

✔ Competitive position,

✔ Earning growth,

✔ Future plans,

✔ Sustainable cash flow etc.

In addition to in-house research, external research like newspapers, database, magazine, reports etc. may be used as an additional source of information.

The Scheme will retain the flexibility to invest in the entire range of debt instruments and money market instruments. Investment in Debt securities and Money Market Instruments will be as per the limits in the asset allocation table of the Scheme, subject to permissible limits laid under SEBI (MF) Regulations.

The portfolio would be structured to incorporate reasonable liquidity using cash and cash equivalents. In-depth credit evaluation of the securities proposed to be invested in will be carried out by the investment team of the AMC for its fixed-income investments.

Who will manage the IDBI Healthcare Fund?

Ms Uma Venkatraman will manage the IDBI Healthcare Fund.

Ms Venkatraman has done her MBA and MS (Finance). She has over 15 years of work experience in the financial services industry, with a focus on equities. Prior to becoming a fund manager, she was heading the Research function in IDBI Mutual Fund. Prior to joining IDBI Mutual Fund, she has worked with B&K Securities; ASK Raymond James, Morgan Keegan and UTI Mutual Fund.

At the IDBI Mutual Fund, some of the other equity mutual fund schemes she manages are: IDBI Banking & Financial Services Fund, IDBI Long Term Value Fund, IDBI India Top 100 Equity Fund, IDBI Small Cap Fund, IDBI Equity Savings Fund, IDBI Equity Advantage Fund and IDBI Hybrid Equity Fund

The outlook for IDBI Healthcare Fund:

The fortune of the fund will be closely associated with the healthcare and allied sectors, which are defensive sectors.

To achieve the stated objective IDBIHF will construct the portfolio as illustrated below:

  • Pick stocks based on Qualitative and quantitative factors

  • Thorough research of the sector and the company using a bottom-up approach

  • Mitigate risk by active management of the sector outlook and select stocks from across market cap

  • Follow a logical and disciplined investment process to invest in a blend of quality stocks.

Diagram 1: Portfolio construction

(Source: IDBI Healthcare Fund Leaflet)


​The fund house believes that the healthcare sector is poised to grow due to the favourable environment for it. In its leaflet the scheme mentions the reasons behind the potential growth in healthcare space:

  • India pharma companies continue to be the preferred supplier of generic pharmaceuticals products to the US to boost exports.

  • Within the healthcare care domain there are many new branches spreading like the Diagnostic, Speciality Hospitals and Insurance - are in the nascent stage.

  • Conducive policy environment - Ayushman Bharat to be an instrument for creating growth in volume domestically

  • Growing awareness within the health industry and rise in disposable incomes has increased the lifespan of individuals has fuelled the demand for healthcare

  • Due to affordability and the quality of care in the country, medical tourism to witness a boost in its revenues.

  • Post the market corrections the stocks of the Pharma sector are reasonably valued

PersonalFN believes that although the markets are correcting with reduced valuations offering good times to invest, one should not ignore the risk involved before investing in a sector fund.

If markets remain volatile in the run-up to 2019 Lok Sabha elections, even healthcare and pharma companies may not be spared. It is also linked to the fund manager's ability to steer from the risk emanating from the wave of Trump policies, US-China Trade War, and going forward even India's relation with the US and rest of the world.

Therefore, although there may be good opportunities, in the long run, the risk also is very high.

[Read: Why Comparing Returns to Risk Is More Meaningful!]

Hence IDBI Healthcare Fund is suitable for the ones, willing to take extremely high risk and have a long investment horizon. It would be wise to assess your own risk appetite and investment horizon before investing in such a fund.

Editor's note: If you're unsure where to invest fresh investible surplus currently, and you're looking for "high investment gains at relatively moderate risk" this ready-made portfolio would be suitable for you.

In this 2019 Edition of PersonalFN's Premium Report, "The Strategic Funds Portfolio For 2025", you will get a ready-made portfolio of its top equity mutual funds schemes for 2025 that have the ability to generate lucrative returns over the long term.

 

PersonalFN's "The Strategic Funds Portfolio for 2025" is geared to potentially multiply your wealth in the years to come. Subscribe now!

DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, its subsidiaries and its Directors.

Terms and condition on which its offer research report

For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Private Limited;

  2. PersonalFN Insurance Services India Private Limited;

  3. Equitymaster Agora Research Private Limited;

  4. Common Sense Living Private Limited;

  5. Quantum Advisors Private Limited;

  6. Quantum Asset Management Company Private Limited;

  7. HelpYourNGO.com India Private Limited;

  8. HelpYourNGO Foundation;

  9. Natural Streets for Performing Arts Foundation;

  10. Primary Real Estate Advisors Private Limited;

  11. HYNGO India Private Limited;

  12. Rahul Goel;

  13. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
  1. ‘subject company’ is a company on which a buy/sell/hold view or target price is given/changed in this Research Report;

  2. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company;

  3. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;

  4. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.

Disclosure with regard to receipt of Compensation
 
  1. Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;

  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;

  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;

  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.

  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report

General disclosure
  1. The Research Analyst has not served as an officer, director or employee of the subject Company.

  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.

Definitions of Terms Used
  1. Buy recommendation:This means that the subscriber could consider buying the concerned fund keeping in mind the tenure and objective of the recommendation service.

  2. Hold recommendation:This means that the subscriber could consider holding on to the fund until further update. However, additional purchase via ongoing SIP can be considered.

  3. Sell recommendation: This means that the subscriber could consider selling the fund keeping in mind the objective of the recommendation service.

Click here to read PersonalFN’s Mutual Fund Rating Methodology

Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Corp. Office: 16 Jolly Maker Chambers II, Nariman Point, Mumbai 400 021. Email: info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222

SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013



Add Comments

Financial News. Simplified


Knowledge Center


Money Simplified Guides (FREE)


Mutual Fund Fact Sheets


Tools & Calculators